MONOCOR   -(5MG) TABLET Canadà - anglès - Health Canada

monocor -(5mg) tablet

biovail pharmaceuticals canada division of biovail corporation - bisoprolol fumarate - tablet - 5mg - bisoprolol fumarate 5mg - beta-adrenergic blocking agents

MONOCOR         -(10MG) TABLET Canadà - anglès - Health Canada

monocor -(10mg) tablet

biovail pharmaceuticals canada division of biovail corporation - bisoprolol fumarate - tablet - 10mg - bisoprolol fumarate 10mg - beta-adrenergic blocking agents

MONOCORD 40 Israel - anglès - Ministry of Health

monocord 40

dexcel ltd, israel - isosorbide mononitrate - tablets - isosorbide mononitrate 40 mg - isosorbide mononitrate - isosorbide mononitrate - for the treatment of angina pectoris and prevention of anginal attacks, treatment of congestive heart failure.

MONOCORD 20 Israel - anglès - Ministry of Health

monocord 20

dexcel ltd, israel - isosorbide mononitrate - tablets - isosorbide mononitrate 20 mg - isosorbide mononitrate - isosorbide mononitrate - for the treatment of angina pectoris and prevention of anginal attacks. treatment of congestive heart failure.

MONOCORD 50 S.R Israel - anglès - Ministry of Health

monocord 50 s.r

dexcel ltd, israel - isosorbide mononitrate - tablets slow release - isosorbide mononitrate 50 mg - isosorbide mononitrate - for the treatment of angina pectoris and prevention of angina attacks.

SCANDONEST L- mepivacaine hydrochloride and levonordefrin injection, solution Estats Units - anglès - NLM (National Library of Medicine)

scandonest l- mepivacaine hydrochloride and levonordefrin injection, solution

novocol pharmaceutical of canada, inc - mepivacaine hydrochloride (unii: 4vfx2l7em5) (mepivacaine - unii:b6e06qe59j), levonordefrin (unii: v008l6478d) (levonordefrin - unii:v008l6478d) - mepivacaine hydrochloride 20 mg in 1 ml - mepivacaine is indicated for production of local anesthesia for dental procedures by infiltration or nerve block in adults and pediatric patients. scandonest® is contraindicated in patients with a known hypersensitivity to amide-type local anesthetics.

BUPIVACAINE HCL 0.5% AND EPINEPHRINE 1:200,000 INJECTION SOLUTION Canadà - anglès - Health Canada

bupivacaine hcl 0.5% and epinephrine 1:200,000 injection solution

novocol pharmaceutical of canada inc - bupivacaine hydrochloride; epinephrine bitartrate - solution - 5mg; 0.0091mg - bupivacaine hydrochloride 5mg; epinephrine bitartrate 0.0091mg - local anesthetics

POSICAINE N SOLUTION Canadà - anglès - Health Canada

posicaine n solution

novocol pharmaceutical of canada inc - articaine hydrochloride; epinephrine (epinephrine bitartrate) - solution - 40mg; 0.005mg - articaine hydrochloride 40mg; epinephrine (epinephrine bitartrate) 0.005mg - vasoconstrictors

POSICAINE SP SOLUTION Canadà - anglès - Health Canada

posicaine sp solution

novocol pharmaceutical of canada inc - articaine hydrochloride; epinephrine (epinephrine bitartrate) - solution - 40mg; 0.01mg - articaine hydrochloride 40mg; epinephrine (epinephrine bitartrate) 0.01mg - vasoconstrictors

CEFAZOLIN SANDOZ cefazolin 2g (as sodium) powder for injection infusion bottle Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

cefazolin sandoz cefazolin 2g (as sodium) powder for injection infusion bottle

sandoz pty ltd - cefazolin sodium, quantity: 2096 mg (equivalent: cefazolin, qty 2000 mg) - injection, powder for - excipient ingredients: - treatment of the following serious infections due to susceptible organisms: respiratory tract infections due to strep. pneumoniae, klebsiella sp., h. influenzae, staph. aureus (penicillin sensitive and penicillin resistant) and group a beta-haemolytic streptococci. injectable benzathine penicillin is considered to be the drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cephazolin is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cephazolin in the subsequent prevention of rheumatic fever are not available at present. genitourinary tract infections due to e. coli, p. mirabilis, and klebsiella sp. and some strains of enterobacter and enterococci. skin and skin structure infections due to staph. aureus (penicillin sensitive and penicillin resisant) and group a beta-haemolytic streptococci and other strains of streptococci. bone and joint infections due to staph. aureus. septicaemia due to strep. pneumoniae, staph. aureus (penicillin sensitive and penicillin resistant), e. coli, p. mirabilis, and klebsiella sp. endocarditis due to staph. aureus (penicillin sensitive and penicillin resistant) and group a beta-haemolytic streptococci. note: appropriate culture and susceptibility studies should be preformed to determine susceptibility of the causative organism to cephazolin.